CN102091258A - 一种祛除疤痕的中药组合物及其制备方法 - Google Patents
一种祛除疤痕的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102091258A CN102091258A CN2011100502697A CN201110050269A CN102091258A CN 102091258 A CN102091258 A CN 102091258A CN 2011100502697 A CN2011100502697 A CN 2011100502697A CN 201110050269 A CN201110050269 A CN 201110050269A CN 102091258 A CN102091258 A CN 102091258A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- blood
- cicatrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 231100000241 scar Toxicity 0.000 title claims abstract description 56
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 208000032544 Cicatrix Diseases 0.000 title claims abstract description 15
- 230000037387 scars Effects 0.000 title claims abstract description 7
- 238000002360 preparation method Methods 0.000 title claims description 28
- 239000003814 drug Substances 0.000 claims abstract description 173
- 239000004863 Frankincense Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims description 50
- 241000628997 Flos Species 0.000 claims description 44
- 210000000582 semen Anatomy 0.000 claims description 43
- 239000000843 powder Substances 0.000 claims description 34
- 239000002674 ointment Substances 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 23
- 244000293323 Cosmos caudatus Species 0.000 claims description 22
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 22
- 241000180649 Panax notoginseng Species 0.000 claims description 21
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 21
- 241000717739 Boswellia sacra Species 0.000 claims description 19
- 241000756943 Codonopsis Species 0.000 claims description 19
- 241001057584 Myrrha Species 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 239000009286 sanguis draxonis Substances 0.000 claims description 17
- 241001489978 Eupolyphaga Species 0.000 claims description 15
- 241000237636 Pheretima Species 0.000 claims description 15
- 239000006187 pill Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- 241000545442 Radix Species 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 8
- 241001126925 Lobata Species 0.000 claims description 6
- 241000698291 Rugosa Species 0.000 claims description 6
- 241000736026 Sarcandra Species 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- -1 electuary Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000013618 particulate matter Substances 0.000 claims description 5
- 239000011505 plaster Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 229940098465 tincture Drugs 0.000 claims description 4
- 238000010410 dusting Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 229940040145 liniment Drugs 0.000 claims description 3
- 239000000865 liniment Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 130
- 210000004369 blood Anatomy 0.000 abstract description 129
- 230000000694 effects Effects 0.000 abstract description 65
- 230000008961 swelling Effects 0.000 abstract description 23
- 208000014674 injury Diseases 0.000 abstract description 18
- 208000003251 Pruritus Diseases 0.000 abstract description 16
- 206010039580 Scar Diseases 0.000 abstract description 15
- 210000002435 tendon Anatomy 0.000 abstract description 11
- 230000003213 activating effect Effects 0.000 abstract description 10
- 206010020718 hyperplasia Diseases 0.000 abstract description 9
- 230000002040 relaxant effect Effects 0.000 abstract description 8
- 230000007803 itching Effects 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 238000001356 surgical procedure Methods 0.000 abstract description 4
- 230000008733 trauma Effects 0.000 abstract description 3
- 241000132012 Atractylodes Species 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 4
- 241001050741 Dipsacus asperoides Species 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 235000017303 Althaea rosea Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000218033 Hibiscus Species 0.000 abstract 1
- 235000017881 Hibiscus moscheutos subsp moscheutos Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000280244 Luffa acutangula Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000220317 Rosa Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000007180 rose mallow Nutrition 0.000 abstract 1
- 210000000589 cicatrix Anatomy 0.000 description 93
- 230000001737 promoting effect Effects 0.000 description 66
- 208000002193 Pain Diseases 0.000 description 60
- 230000036407 pain Effects 0.000 description 56
- 208000027418 Wounds and injury Diseases 0.000 description 49
- 210000003491 skin Anatomy 0.000 description 45
- 206010052428 Wound Diseases 0.000 description 43
- 230000017531 blood circulation Effects 0.000 description 36
- 238000011282 treatment Methods 0.000 description 33
- 230000006870 function Effects 0.000 description 29
- 238000005469 granulation Methods 0.000 description 24
- 230000003179 granulation Effects 0.000 description 24
- 208000033809 Suppuration Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 22
- 231100000614 poison Toxicity 0.000 description 22
- 238000012360 testing method Methods 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 20
- 230000029663 wound healing Effects 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 18
- 238000000034 method Methods 0.000 description 16
- 210000003205 muscle Anatomy 0.000 description 16
- 230000003203 everyday effect Effects 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 206010007247 Carbuncle Diseases 0.000 description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 description 14
- 208000006820 Arthralgia Diseases 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 13
- 210000000988 bone and bone Anatomy 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 208000025865 Ulcer Diseases 0.000 description 12
- 241000411851 herbal medicine Species 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 231100000397 ulcer Toxicity 0.000 description 11
- 235000013372 meat Nutrition 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 239000002574 poison Substances 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 206010053615 Thermal burn Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 230000008736 traumatic injury Effects 0.000 description 9
- 206010010904 Convulsion Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 208000025747 Rheumatic disease Diseases 0.000 description 8
- 230000036461 convulsion Effects 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000002398 materia medica Substances 0.000 description 8
- 230000000552 rheumatic effect Effects 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010062575 Muscle contracture Diseases 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 206010000496 acne Diseases 0.000 description 7
- 208000006111 contracture Diseases 0.000 description 7
- 230000001186 cumulative effect Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000008520 organization Effects 0.000 description 7
- 229940023488 pill Drugs 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229940099259 vaseline Drugs 0.000 description 7
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 6
- 208000019255 Menstrual disease Diseases 0.000 description 6
- 208000004680 Rectal Fistula Diseases 0.000 description 6
- 206010040943 Skin Ulcer Diseases 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 206010002156 anal fistula Diseases 0.000 description 6
- 238000010171 animal model Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 239000007766 cera flava Substances 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 210000002808 connective tissue Anatomy 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000017423 tissue regeneration Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000003255 anti-acne Effects 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000004247 hand Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 3
- 241000581650 Ivesia Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 201000010582 ecthyma Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 210000000835 hypertrophic cicatrix Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000009416 jing wan hong Substances 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000003814 Interleukin-10 Human genes 0.000 description 2
- 108090000174 Interleukin-10 Proteins 0.000 description 2
- 102000004890 Interleukin-8 Human genes 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010029098 Neoplasm skin Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 240000006064 Urena lobata Species 0.000 description 2
- 235000015414 Urena lobata Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229940076144 interleukin-10 Drugs 0.000 description 2
- 229940096397 interleukin-8 Drugs 0.000 description 2
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000010201 sheng-ji-san Substances 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 206010060954 Abdominal Hernia Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001415830 Bubo Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108010024212 E-Selectin Proteins 0.000 description 1
- 102100023471 E-selectin Human genes 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 101000837626 Homo sapiens Thyroid hormone receptor alpha Proteins 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 240000003146 Lobelia chinensis Species 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000193418 Paenibacillus larvae Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000032536 Pseudomonas Infections Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102100028702 Thyroid hormone receptor alpha Human genes 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000016335 bubo Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- WABYCCJHARSRBH-UHFFFAOYSA-N metaclazepam Chemical compound C12=CC(Br)=CC=C2N(C)C(COC)CN=C1C1=CC=CC=C1Cl WABYCCJHARSRBH-UHFFFAOYSA-N 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 动物数(只) | 用药后伤口愈合(%) |
空白组 | 9 | 35.05±29.72 |
京万红烧伤膏组 | 9 | 75.52±22.16 |
本发明药物散剂组 | 9 | 91.32±12.47 |
组别 | n | 创面愈合时间(D) | 平均愈合时间(D) |
一般创面组 | 8 | 15-20 | 28.28±1.67 |
本发明膏剂 | 8 | 18-25 | 16.27±2.15** |
凡士林组组 | 8 | 17-22 | 24.37±2.32 |
美宝疤痕平组 | 8 | 18-24 | 20.89±2.46 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100502697A CN102091258B (zh) | 2011-03-03 | 2011-03-03 | 一种祛除疤痕的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100502697A CN102091258B (zh) | 2011-03-03 | 2011-03-03 | 一种祛除疤痕的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102091258A true CN102091258A (zh) | 2011-06-15 |
CN102091258B CN102091258B (zh) | 2012-07-25 |
Family
ID=44124638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100502697A Expired - Fee Related CN102091258B (zh) | 2011-03-03 | 2011-03-03 | 一种祛除疤痕的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102091258B (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225124A (zh) * | 2011-06-18 | 2011-10-26 | 王心宝 | 一种治疗臁疮腿、皮肤溃烂的膏药 |
CN102327321A (zh) * | 2011-09-30 | 2012-01-25 | 赵治贵 | 治疗“羊毛疔”的中药制剂 |
CN103211742A (zh) * | 2011-09-27 | 2013-07-24 | 沈志荣 | 一种含美洲接骨木提取物、三色堇花提取物和水解珍珠的瞬透生肌水组合物的制备方法 |
CN103285297A (zh) * | 2013-05-30 | 2013-09-11 | 潘光全 | 一种速效冻伤酊及其制备方法 |
CN103800452A (zh) * | 2014-03-17 | 2014-05-21 | 天津嘉氏堂科技有限公司 | 一种抑制增生性疤痕的中药组合物及制备方法及用途 |
CN103933359A (zh) * | 2014-05-05 | 2014-07-23 | 王萍萍 | 用于祛除瘢痕疙瘩的药物组合物及其制备方法 |
CN104524412A (zh) * | 2014-12-22 | 2015-04-22 | 刘祥锋 | 一种用于股骨干骨折手术后早期治疗的药物及制备方法 |
CN104524554A (zh) * | 2014-12-22 | 2015-04-22 | 陈晨 | 一种消除疤痕的药物 |
CN104758857A (zh) * | 2015-04-29 | 2015-07-08 | 赵振荣 | 一种治疗皮肤瘢痕瘀毒聚结证的药膏及其制备方法 |
CN104784455A (zh) * | 2015-04-30 | 2015-07-22 | 姜振玲 | 一种用于腹部术后防瘢痕形成的中药制剂及其制备方法 |
CN105030902A (zh) * | 2015-07-15 | 2015-11-11 | 江苏奇力康皮肤药业有限公司 | 一种祛除疤痕的中药膏及其制备方法 |
CN105125783A (zh) * | 2015-09-02 | 2015-12-09 | 安徽金马药业有限公司 | 一种祛疤贴膏 |
CN105233269A (zh) * | 2015-11-23 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种治疗局部灼伤的药物组合物 |
CN105233268A (zh) * | 2015-11-23 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种治疗局部灼伤的外用药膏 |
CN105920213A (zh) * | 2016-04-28 | 2016-09-07 | 邱定武 | 一种治疗术后疤痕结缔组织增生的药贴及其制备方法 |
CN105999154A (zh) * | 2016-06-07 | 2016-10-12 | 宋伟亮 | 祛疤液及其制备方法 |
CN106266600A (zh) * | 2016-10-09 | 2017-01-04 | 冉德学 | 疤痕萎缩软化贴 |
CN110013530A (zh) * | 2019-04-22 | 2019-07-16 | 厦门市中萪研生物科技有限公司 | 一种皮肤修复原液及其制备方法 |
CN110732005A (zh) * | 2019-12-12 | 2020-01-31 | 河南中医药大学 | 一种外用治疗瘢痕的桃七参精油 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162467A (zh) * | 1996-04-12 | 1997-10-22 | 鞍山钢铁集团公司 | 一种治疗疤痕的外用药 |
CN1454653A (zh) * | 2003-01-08 | 2003-11-12 | 杨慈元 | 创疮康 |
CN101214293A (zh) * | 2008-01-17 | 2008-07-09 | 刘兆森 | 一种治疗痤疮及痤疮疤痕的中药制剂及其制备方法 |
-
2011
- 2011-03-03 CN CN2011100502697A patent/CN102091258B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162467A (zh) * | 1996-04-12 | 1997-10-22 | 鞍山钢铁集团公司 | 一种治疗疤痕的外用药 |
CN1454653A (zh) * | 2003-01-08 | 2003-11-12 | 杨慈元 | 创疮康 |
CN101214293A (zh) * | 2008-01-17 | 2008-07-09 | 刘兆森 | 一种治疗痤疮及痤疮疤痕的中药制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
《国医论坛》 20020930 伍成奇等 中西医结合治疗疤痕临床体会 37 1-10 , 第05期 2 * |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225124B (zh) * | 2011-06-18 | 2013-03-27 | 王心宝 | 一种治疗臁疮腿、皮肤溃烂的膏药 |
CN102225124A (zh) * | 2011-06-18 | 2011-10-26 | 王心宝 | 一种治疗臁疮腿、皮肤溃烂的膏药 |
CN103211742B (zh) * | 2011-09-27 | 2015-09-16 | 浙江欧诗漫生物股份有限公司 | 一种含美洲接骨木提取物、三色堇花提取物和水解珍珠的瞬透生肌水组合物的制备方法 |
CN103211742A (zh) * | 2011-09-27 | 2013-07-24 | 沈志荣 | 一种含美洲接骨木提取物、三色堇花提取物和水解珍珠的瞬透生肌水组合物的制备方法 |
CN102327321A (zh) * | 2011-09-30 | 2012-01-25 | 赵治贵 | 治疗“羊毛疔”的中药制剂 |
CN103285297A (zh) * | 2013-05-30 | 2013-09-11 | 潘光全 | 一种速效冻伤酊及其制备方法 |
CN103800452A (zh) * | 2014-03-17 | 2014-05-21 | 天津嘉氏堂科技有限公司 | 一种抑制增生性疤痕的中药组合物及制备方法及用途 |
CN103933359A (zh) * | 2014-05-05 | 2014-07-23 | 王萍萍 | 用于祛除瘢痕疙瘩的药物组合物及其制备方法 |
CN104524412A (zh) * | 2014-12-22 | 2015-04-22 | 刘祥锋 | 一种用于股骨干骨折手术后早期治疗的药物及制备方法 |
CN104524554A (zh) * | 2014-12-22 | 2015-04-22 | 陈晨 | 一种消除疤痕的药物 |
CN104758857A (zh) * | 2015-04-29 | 2015-07-08 | 赵振荣 | 一种治疗皮肤瘢痕瘀毒聚结证的药膏及其制备方法 |
CN104784455A (zh) * | 2015-04-30 | 2015-07-22 | 姜振玲 | 一种用于腹部术后防瘢痕形成的中药制剂及其制备方法 |
CN105030902A (zh) * | 2015-07-15 | 2015-11-11 | 江苏奇力康皮肤药业有限公司 | 一种祛除疤痕的中药膏及其制备方法 |
CN105125783A (zh) * | 2015-09-02 | 2015-12-09 | 安徽金马药业有限公司 | 一种祛疤贴膏 |
CN105233269A (zh) * | 2015-11-23 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种治疗局部灼伤的药物组合物 |
CN105233268A (zh) * | 2015-11-23 | 2016-01-13 | 桂林华诺威基因药业有限公司 | 一种治疗局部灼伤的外用药膏 |
CN105920213A (zh) * | 2016-04-28 | 2016-09-07 | 邱定武 | 一种治疗术后疤痕结缔组织增生的药贴及其制备方法 |
CN105999154A (zh) * | 2016-06-07 | 2016-10-12 | 宋伟亮 | 祛疤液及其制备方法 |
CN106266600A (zh) * | 2016-10-09 | 2017-01-04 | 冉德学 | 疤痕萎缩软化贴 |
CN110013530A (zh) * | 2019-04-22 | 2019-07-16 | 厦门市中萪研生物科技有限公司 | 一种皮肤修复原液及其制备方法 |
CN110732005A (zh) * | 2019-12-12 | 2020-01-31 | 河南中医药大学 | 一种外用治疗瘢痕的桃七参精油 |
Also Published As
Publication number | Publication date |
---|---|
CN102091258B (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN102049008B (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN101496844B (zh) | 一种治疗白癜风的外用制剂及其制备方法 | |
CN101810685B (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103768567B (zh) | 一种黑膏药及其制备方法 | |
CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN103638250B (zh) | 一种治疗面神经麻痹的中药制剂及其制备方法 | |
CN104069474B (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
CN105616318A (zh) | 一种抗皱紧肤的积雪草中药面膜及其制备方法 | |
CN102872286B (zh) | 一种治疗腰间盘突出的中药组合物及其制备方法 | |
CN104013868A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN102846955A (zh) | 一种中药增高鞋垫 | |
CN102772712A (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN102908474B (zh) | 一种治疗神经官能症的药酒 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN105194487A (zh) | 一种美白养颜中药组合物及其面膜和制备方法 | |
CN104147460A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN102091254B (zh) | 一种用于面部整容后消肿的中药组合物及其制备方法 | |
CN104524397A (zh) | 一种用于中风辅助康复的中药组合物及其制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104689240A (zh) | 一种治疗气滞血瘀型黄褐斑的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG WEEK TOURISM DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: WU QIANG Effective date: 20130802 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 273500 JINING, SHANDONG PROVINCE TO: 226121 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130802 Address after: 226121 Jiangsu province Nantong markets three factory town Road No. 79 Patentee after: NANTONG SUNDAY TOURISM DEVELOPMENT CO.,LTD. Address before: 273500 Shandong city of Zoucheng province Tiexi Kuangjian Road No. 560 (Yankuang Group Hospital) Patentee before: Wu Qiang |
|
TR01 | Transfer of patent right |
Effective date of registration: 20181024 Address after: 344000 70 building, A10 building, business incubation base, Fuzhou hi tech Industrial Development Zone, Fuzhou, Jiangxi, China. 2 Patentee after: Jiangxi Bofen Medical Devices Co.,Ltd. Address before: 226121 No. three vegetable market road, three factory town, Nantong, Jiangsu Patentee before: NANTONG SUNDAY TOURISM DEVELOPMENT CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 |
|
CF01 | Termination of patent right due to non-payment of annual fee |